Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05358548
Title	ATATcH Alternating Treatment Plans for Advanced Cancer
Recruitment	Recruiting
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	Rutgers, The State University of New Jersey
Indications	lung non-squamous non-small cell carcinoma hypopharynx cancer lung non-small cell carcinoma oral cavity cancer oropharynx cancer laryngeal squamous cell carcinoma lung squamous cell carcinoma head and neck squamous cell carcinoma
Therapies	Carboplatin + Paclitaxel + Pembrolizumab Carboplatin + Pembrolizumab + Pemetrexed Disodium Carboplatin + Fluorouracil + Pembrolizumab
Age Groups:	adult \| senior
Covered Countries	USA